The enzymes market is expanding steadily due to rising demand across industries such as food and beverages, pharmaceuticals, animal nutrition, biofuels, and healthcare. Enzymes are biological catalysts that speed up chemical reactions, making them essential in various industrial and medical processes. With growing emphasis on eco-friendly solutions and sustainable production, enzymes are increasingly being used as natural alternatives to chemicals. Technological advancements and increasing awareness of enzyme-based applications are expected to drive market growth globally in the coming years.
According to Fortune Business Insights, the global enzymes market was valued at USD 9,008.7 million in 2019 and is expected to grow from USD 8,919.8 million in 2020 to USD 13,815.2 million by 2027, exhibiting a CAGR of 6.4% during the 2020–2027 period. In 2019, North America dominated the enzymes market with a market share of 39.78%.
These industry leaders continue to shape the enzymes market through strategic investments in R&D, licensing agreements, and technological innovation.
In December 2023, Aldevron and Codexis, Inc. entered a global licensing agreement for Codex HiCap RNA Polymerase. This significant collaboration aims to enhance commercial access and streamline manufacturing for mRNA-based therapeutics—a clear sign of enzymes playing a critical role in next-generation biopharma.